Mozambique is now the rapporteur for the African Union’s Continental Forum on Drug Registration, a regulatory community focused on improving public health outcomes in Africa.
Mozambique is represented on the continental body by the National Medicines Regulatory Authority (ANARME).
Mozambique’s appointment took place this week in Nairobi, Kenya.
A press release from ANARME sent to Agência de Informação de Moçambique (AIM) on Saturday (13) states that Mozambique’s election took place on Wednesday and Thursday of this week during the first forum of Africa’s drug registration and marketing authorisation directors.
The election represents a gain for Mozambique because it strengthens the mechanisms for recognising continental scientific methodologies for the introduction of medicines onto the national market.
The introduction of medicines on the domestic market reduces the likelihood of counterfeit and low-quality drugs circulating in the country.
For the Forum’s coordinators, the event is an asset for building the regional harmonisation initiative to strengthen the regulatory system in the Forum’s member countries.
Mozambique is represented at the Forum by the directorate of the Medicines, Biological and Health Products Evaluation Division at ANARME.
Organised by the African Union, through the African Union Development Agency (AUDA), the meeting aimed to discuss the pilot phase of the joint continental evaluation of drug registration applications.
AIM
